Treatment of Retinal/Choroidal Vascular Diseases by Sustained Delivery of VEGF Receptor Tyrosine Kinase Inhibitors. Dhoot DS. Am J Ophthalmol 2025 Jun 10:S0002-9394(25)00296.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dhoot DS. Treatment of Retinal/Choroidal Vascular Diseases by Sustained Delivery of VEGF Receptor Tyrosine Kinase Inhibitors. Am J Ophthalmol 2025 Jun 10:S0002-9394(25)00296.
PMID: 40505850